Showing results (1511-1520 of 2,025) with videos related to
Sort By:
Pageof 203
PLOS Global Public Health|January 8, 2026
A cost-consequence analysis of the children's administration oxygenation strategies trial (COAST) in severe pneumoniaOrlagh U Carroll, Richard Grieve, Sarah Kiguli, et al.ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.Clinical Epidemiology|June 2, 2026
Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple MyelomaDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.European Journal of Medicinal Chemistry|June 26, 2026
Dual-target mu opioid-dopamine D3 receptor (MOR-D3R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesicsKhorshada Jahan, Grant Glatfelter, Julie Sanchez, et al.Pharmacogenomics|May 23, 2018
Variants in genes coding for glutathione S-transferases and asthma outcomes in childrenSteve Turner, Ben Francis, Nuha Wani, et al.American Journal of Hematology|November 24, 2017
The clinical epidemiology of sickle cell anemia In AfricaAlex W Macharia, George Mochamah, Sophie Uyoga, et al.The Journal of Infectious Diseases|March 3, 2026
Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East AfricaTimothy O Makori, Elijah T Gicheru, Maureen W Mburu, et al.The Journal of Allergy and Clinical Immunology|September 3, 2019
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and managementCatherine R Weiler, K Frank Austen, Cem Akin, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|December 18, 2010
Genetic variation in the renin--angiotensin system, use of renin--angiotensin system inhibitors and the risk of myocardial infarctionAnke-Hilse Maitland-van der Zee, Diane Bma van Wieren-de Wijer, Anthonius de Boer, et al.Science (New York, N.Y.)|July 31, 1999
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptorsH D Brightbill, D H Libraty, S R Krutzik, et al.Pageof 203